ストックスクリーナーアプリを入手
8.47
0.59%
-0.05
アフターアワーズ：
8.47
前日終値:
$8.52
開ける：
$8.58
24時間の取引高:
1.80M
Relative Volume:
0.55
時価総額：
$1.78B
収益：
$557.51M
当期純損益:
$-35.71M
株価収益率:
-47.06
EPS:
-0.18
ネットキャッシュフロー:
$15.50M
1週間 パフォーマンス:
+1.07%
1か月 パフォーマンス:
+2.54%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
-0.94%
1日の値動き範囲:
$8.40
$8.61
1週間の範囲:
$8.27
$8.675
52週間の値動き範囲:
$6.015
$11.31
Biocryst Pharmaceuticals Inc Stock (BCRX) Company Profile
名前
Biocryst Pharmaceuticals Inc
セクター
電話
919-859-1302
住所
4505 EMPEROR BOULEVARD, DURHAM, NC
BCRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCRX
Biocryst Pharmaceuticals Inc
|
8.47 | 1.79B | 557.51M | -35.71M | 15.50M | -0.18 |
|
ZTS
Zoetis Inc
|
154.79 | 68.86B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.97 | 46.93B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.04 | 20.71B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
307.24 | 13.81B | 2.99B | 1.21B | 1.13B | 25.06 |
Biocryst Pharmaceuticals Inc Stock (BCRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-02-25 | 開始されました | Wedbush | Outperform |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-09-18 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-08-04 | アップグレード | Jefferies | Hold → Buy |
| 2023-07-13 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-02-22 | アップグレード | Needham | Hold → Buy |
| 2022-11-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-08-05 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-08-05 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-04-18 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-04-11 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-10 | 開始されました | Oppenheimer | Outperform |
| 2021-08-06 | ダウングレード | Jefferies | Buy → Hold |
| 2021-08-03 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-01 | 開始されました | Cowen | Outperform |
| 2020-09-29 | 再開されました | JP Morgan | Overweight |
| 2020-06-17 | 開始されました | BTIG Research | Neutral |
| 2020-05-05 | アップグレード | Barclays | Equal Weight → Overweight |
| 2019-11-15 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-05-24 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-11-16 | 再開されました | Piper Jaffray | Overweight |
| 2018-08-08 | 再開されました | JP Morgan | Overweight |
| 2018-07-17 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2018-06-22 | 開始されました | Seaport Global Securities | Neutral |
| 2018-01-02 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-12-20 | 開始されました | Barclays | Equal Weight |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2017-09-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2017-09-06 | アップグレード | Jefferies | Hold → Buy |
| 2017-02-16 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-08-12 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2016-08-04 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2016-02-09 | 繰り返されました | FBR Capital | Outperform |
| 2016-02-09 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2016-02-09 | ダウングレード | Needham | Buy → Hold |
すべてを表示
Biocryst Pharmaceuticals Inc (BCRX) 最新ニュース
How to track smart money flows in BioCryst Pharmaceuticals Inc.July 2025 Market Mood & AI Powered Market Entry Strategies - Newser
Will BioCryst Pharmaceuticals Inc. see short term momentumTrade Ideas & AI Enhanced Trading Signals - Newser
Published on: 2025-08-28 22:05:03 - Newser
Understanding BioCryst Pharmaceuticals Inc.’s price movement2025 Price Momentum & Long-Term Safe Return Strategies - Newser
Is a relief rally coming for BioCryst Pharmaceuticals Inc. holdersJuly 2025 Pullbacks & Safe Entry Point Identification - Newser
Published on: 2025-08-28 20:05:01 - Newser
Is BioCryst Pharmaceuticals Inc. forming a bottoming baseWeekly Gains Report & Safe Capital Growth Trade Ideas - Newser
BioCryst Pharmaceuticals Inc. stock prediction for this weekGold Moves & AI Forecast for Swing Trade Picks - Newser
Custom watchlist performance reports with BioCryst Pharmaceuticals Inc.July 2025 Update & AI Forecasted Entry/Exit Points - Newser
What to do if you’re stuck in BioCryst Pharmaceuticals Inc.Breakout Watch & Precise Swing Trade Entry Alerts - Newser
Can you recover from losses in BioCryst Pharmaceuticals Inc.Market Performance Summary & Advanced Technical Analysis Signals - Newser
How to integrate BioCryst Pharmaceuticals Inc. into portfolio analysis tools2025 Year in Review & Technical Confirmation Trade Alerts - Newser
Can technical indicators confirm BioCryst Pharmaceuticals Inc.’s reversalTrade Analysis Report & AI Powered Buy/Sell Recommendations - Newser
Applying Elliott Wave Theory to BioCryst Pharmaceuticals Inc.Market Movers & Fast Gain Swing Trade Alerts - Newser
Using fundamentals and technicals on BioCryst Pharmaceuticals Inc.2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - Newser
Is BioCryst Pharmaceuticals Inc. a candidate for recovery playQuarterly Performance Summary & Fast Moving Market Watchlists - Newser
Real time pattern detection on BioCryst Pharmaceuticals Inc. stockJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - Newser
What MACD and RSI say about BioCryst Pharmaceuticals Inc.Weekly Gains Summary & Stepwise Trade Signal Implementation - Newser
Sentiment analysis tools applied to BioCryst Pharmaceuticals Inc.2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - Newser
How to read the order book for BioCryst Pharmaceuticals Inc.Weekly Loss Report & Consistent Return Strategy Ideas - Newser
Published on: 2025-08-27 20:06:29 - Newser
Is BioCryst Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - Newser
Published on: 2025-08-27 11:33:19 - Newser
What momentum shifts mean for BioCryst Pharmaceuticals Inc.2025 Price Targets & Weekly High Momentum Picks - Newser
Will breakout in BioCryst Pharmaceuticals Inc. lead to full recoveryWeekly Earnings Recap & Real-Time Chart Breakout Alerts - Newser
Automated trading signals detected on BioCryst Pharmaceuticals Inc. - Newser
Chart based exit strategy for BioCryst Pharmaceuticals Inc.Market Performance Summary & Advanced Technical Signal Analysis - Newser
Biocryst Pharmaceuticals Inc (BCRX) 財務データ
収益
当期純利益
現金流量
EPS
1.09%
0.59%
大文字化:
|
ボリューム (24 時間):